(Total Views: 420)
Posted On: 03/18/2020 9:22:08 AM
Post# of 5
For newbies here is a little history for your d/d......
Algernon set to launch mid-stage study of ifenprodil in IPF
Jan. 17, 2020 6:46 AM ET|About: Algernon Pharmaceutica... (AGNPF)|By: Douglas W. House, SA News Editor
Algernon Pharmaceuticals (OTCQB:AGNPF) has engaged CRO Novotech to conduct a Phase 2 clinical trial evaluating ifenprodil (NP-120) in patients with idiopathic pulmonary fibrosis and chronic cough. The study should commence next quarter.
Novotech has also agreed to make an equity investment in Algernon via the purchase of C$220K of units at C$0.085 per unit, each consisting of one common share and one warrant to purchase one common share at C$0.12.
Ifenprodil, originally developed by Sanofi for circulatory disorders under the brand name Cerocal, is an orally available small molecule NDMA receptor glutamate antagonist.
Repurposing Ifenprodil to treat the coronavirus (Covid-19) allows FDA to fast tract this one but funding is needed possibly from the Bill & Lelinda Gates Foundation?
Algernon set to launch mid-stage study of ifenprodil in IPF
Jan. 17, 2020 6:46 AM ET|About: Algernon Pharmaceutica... (AGNPF)|By: Douglas W. House, SA News Editor
Algernon Pharmaceuticals (OTCQB:AGNPF) has engaged CRO Novotech to conduct a Phase 2 clinical trial evaluating ifenprodil (NP-120) in patients with idiopathic pulmonary fibrosis and chronic cough. The study should commence next quarter.
Novotech has also agreed to make an equity investment in Algernon via the purchase of C$220K of units at C$0.085 per unit, each consisting of one common share and one warrant to purchase one common share at C$0.12.
Ifenprodil, originally developed by Sanofi for circulatory disorders under the brand name Cerocal, is an orally available small molecule NDMA receptor glutamate antagonist.
Repurposing Ifenprodil to treat the coronavirus (Covid-19) allows FDA to fast tract this one but funding is needed possibly from the Bill & Lelinda Gates Foundation?
(0)
(0)
